NEW YORK, Oct 5 – Erik Wallden, president and CEO of Pyrosequencing of Uppsala, Sweden, said Thursday his company planned to leverage its sequencing technology to create kits that could eventually be used for clinical diagnostic purposes.

“We would be providing the techniques to sequence small-sized pieces of DNA and we would either license the technology or manufacture the kits,” Wallden told GenomeWeb. He did not say when the clinical diagnostic kit would be available for commercialization.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York City medical examiner is overseeing an effort to identify missing persons using DNA, according to the Associated Press.

Nobel laureate Günter Blobel has died at 81, the New York Times reports.

In PNAS this week: mouse model of genetically induced emphysema, gene expression signatures of circulating melanoma cells, and more.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.